cephalexin has been researched along with fosfomycin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Magaribuchi, T; Ohya, S; Tajima, M; Utsui, Y; Yokota, T | 1 |
| Bottaro, L; Brancadoro, MT; Cicchetti, M; Mangini, P; Messina, V; Puppo, F | 1 |
| Stille, W | 1 |
| Di Nola, F | 1 |
| Butti, A; Civello, IM; Cotogni, P; De Giovanni, L; Destito, C; Reggio, D | 1 |
| Kamimura, T; Neu, HC | 1 |
| Elhanan, G; Raz, R; Tabenkin, H; Yahalom, R | 1 |
| Lobel, B | 1 |
2 review(s) available for cephalexin and fosfomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fosfomycin; Humans; Longitudinal Studies; Meta-Analysis as Topic; Nitrofurantoin; Norfloxacin; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2003 |
3 trial(s) available for cephalexin and fosfomycin
| Article | Year |
|---|---|
A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Fosfomycin; Humans; Male | 1985 |
[Antibiotic prophylaxis with cofosfolactamine in biliary tract surgery: prospective controlled study of different routes of administration].
Topics: Administration, Topical; Aged; Amoxicillin; Cephalexin; Cholecystectomy; Clinical Trials as Topic; Drug Combinations; Female; Fosfomycin; Humans; Injections, Intramuscular; Male; Middle Aged; Premedication; Prospective Studies; Random Allocation | 1983 |
Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cephalexin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Fosfomycin; Humans; Middle Aged; Tromethamine; Urinary Tract Infections | 1994 |
10 other study(ies) available for cephalexin and fosfomycin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus.
Topics: Animals; Bacterial Proteins; Carrier Proteins; Cefmetazole; Cephalexin; Cephamycins; Drug Combinations; Drug Synergism; Fosfomycin; Hexosyltransferases; Humans; Male; Methicillin; Mice; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcal Infections; Staphylococcus aureus | 1986 |
The prognostic value of the antibiogram.
Topics: Amniotic Fluid; Ampicillin; Animals; Anti-Bacterial Agents; Bile; Cefaclor; Cephalexin; Escherichia coli Infections; Fosfomycin; Gentamicins; Humans; In Vitro Techniques; Kanamycin; Klebsiella Infections; Microbial Sensitivity Tests; Urine | 1983 |
[Update on antibiotic therapy. 17) A combination of fosfomycin and cephalexin (cefemic cofosfolactamine)].
Topics: Anti-Bacterial Agents; Binding, Competitive; Cephalexin; Drug Combinations; Drug Synergism; Drug Therapy; Enzyme Inhibitors; Escherichia coli Infections; Fosfomycin; Humans; Klebsiella Infections; Proteus Infections; Salmonella Infections; Staphylococcal Infections; Streptococcal Infections | 1983 |
In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Carbenicillin; Cephalexin; Culture Media; Fosfomycin; Male; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Sulfamethoxazole; Trimethoprim | 1981 |